000 01206 a2200349 4500
005 20250511130542.0
264 0 _c19781025
008 197810s 0 0 eng d
022 _a0039-6109
024 7 _a10.1016/s0039-6109(16)41591-4
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aWeick, J K
245 0 0 _aOvarian suppression and breast cancer.
_h[electronic resource]
260 _bThe Surgical clinics of North America
_cAug 1978
300 _a795-800 p.
_bdigital
500 _aPublication Type: Clinical Trial; Comparative Study; Journal Article
650 0 4 _aAntineoplastic Agents
_xtherapeutic use
650 0 4 _aBreast Neoplasms
_xtherapy
650 0 4 _aCastration
650 0 4 _aClinical Trials as Topic
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aNeoplasm Metastasis
650 0 4 _aNeoplasms, Multiple Primary
_xtherapy
650 0 4 _aOvary
_xdrug effects
650 0 4 _aRecurrence
650 0 4 _aSteroids
_xtherapeutic use
650 0 4 _aTime Factors
700 1 _aCooperman, A M
773 0 _tThe Surgical clinics of North America
_gvol. 58
_gno. 4
_gp. 795-800
856 4 0 _uhttps://doi.org/10.1016/s0039-6109(16)41591-4
_zAvailable from publisher's website
999 _c378737
_d378737